Skip to main content
. 2009 Apr 7;4:12. doi: 10.1186/1748-717X-4-12

Figure 3.

Figure 3

Overall survival (OS): the delay of OS was calculated by the date of histological diagnosis until the death or until the date of last news. The median follow-up, the rate of overall survival in five years, and the number of patients censored were presented. Group A (anthracycline): N = 110 (19 events, 91 censored); Group B (CMF): N = 134 (29 events, 105 censored); Survival probability at five years: 82.5% in group A vs 81.1% in group B; Log-rank test: p = 0.428.